(Q36834360)

16 August 2017

1 reference

title

Solar keratosis: epidemiology, pathogenesis, presentation and treatment (English)

1 reference

16 August 2017

1 reference

1 reference

Cara Holmes

1

1 reference

16 August 2017

Peter Foley

series ordinal

2

1 reference

16 August 2017

Michael Freeman

series ordinal

3

1 reference

16 August 2017

Alvin H Chong

series ordinal

4

1 reference

16 August 2017

1 May 2007

1 reference

Australasian Journal of Dermatology

16 August 2017

1 reference

16 August 2017

48

1 reference

16 August 2017

67-74; quiz 75-6

1 reference

16 August 2017

2

1 reference

The risk of progression to invasive disease

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Actinic keratosis: epidemiology and progression to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Prevalence of solar damage and actinic keratosis in a Merseyside population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971-1974.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

The scientific basis of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

The actinic (solar) keratosis: a 21st-century perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Clinical presentation of actinic keratoses and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Reduction of solar keratoses by regular sunscreen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Malignant transformation of solar keratoses to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Clinical recognition of actinic keratoses in a high-risk population: how good are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

The majority of cutaneous squamous cell carcinomas arise in actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

High rate of malignant transformation in hyperkeratotic actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

High incidence and regression rates of solar keratoses in a queensland community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

The treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Prevention of Immunosuppression by Sunscreens in Humans Is Unrelated to Protection from Erythema and Dependent on Protection from Ultraviolet A in the Face of Constant Ultraviolet B Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

High sun protection factor sunscreens in the suppression of actinic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

A prospective study of the use of cryosurgery for the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Destructive procedures are the standard of care for treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Cryosurgery of benign skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Guidelines of care for actinic keratoses. Committee on Guidelines of Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Photodynamic therapy in dermatology--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Imiquimod; an international update on therapeutic uses in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Actinic keratosis. Current treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Topical diclofenac in hyaluronan gel for the treatment of solar keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Er:YAG laser for the treatment of actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

Assessment of a new device for injecting bovine collagen. The ADG needle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00339.X

10.1111/J.1440-0960.2007.00339.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference